Global Molecular Imaging Procedures Growth Opportunities
The Development of Novel Radiopharmaceuticals and the Expanding Clinical Applications for Molecular Imaging Equipment will Create Opportunities for the Growth of Procedures
22-Feb-2022
North America
Market Research
PCB3-01-00-00-00
HC03510-NA-MT_26299
This Frost & Sullivan research service presents an analysis of the global molecular imaging (MI) procedures market and an overview of the development of novel radiopharmaceuticals. It offers an in-depth analysis of current trends and a forecast for PET/CT and SPECT/CT procedures. The study also outlines healthcare infrastructure and MI procedure volumes in the United States and EU-5 countries, including Germany, France, Italy, the United Kingdom, and Spain.
More than 36 million MI procedures are carried out, globally, and this number is increasing by 4%–6%, annually, driven by the rising number of patients with cancer, cardiac disease, and neurological ailments. Owing to the surging MI procedures, demand for the in-house production of radioisotopes using cyclotrons is rising. In addition, due to technology advancements and investments in R&D, new radiotracers have been developed, which has expanded the clinical application of MI equipment in neurology and oncology.
Why Is It Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top Three Strategic Imperatives on the Molecular Imaging (MI) Procedures Industry
Growth Opportunities Fuel the Growth Pipeline Engine™
Scope of Analysis
Market Segmentation
Therapeutic Indications
Molecular Imaging Procedures Ecosystem—Present and Future
Key Highlights
Key Growth Metrics
Procedures Forecast
Procedures Forecast by Product Segment
COVID-19 Impact and Challenges Outlook, 2022
PET/CT Procedures by Clinical Application
Procedure Volume by Clinical Application
Procedure Volume by Geography
Key Trends—The Introduction of New Radiopharmaceuticals will Accelerate the Growth of PET/CT Imaging Procedures
Key Trends—The Next Big Opportunity for PET Scanning Lies in its Potential to Aid the Diagnosis of Alzheimer’s Disease
SPECT/CT Procedures by Clinical Application
Procedure Volume by Clinical Application
Procedure Volume by Geography
Technology is Set to Take Center Stage
Key Trends—Expansion of the Installed Base of Cyclotrons for the In-house Production of Radiotracers
Key Trends—Expansion of the Installed Base of Cyclotrons for the In-house Production of Radiotracers (continued)
Hospital Landscape and MI Equipment Infrastructure—United States
Hospital Landscape and MI Equipment Infrastructure—Germany
Hospital Landscape and MI Equipment Infrastructure—France
Hospital Landscape and MI Equipment Infrastructure—Italy
Hospital Landscape and MI Equipment Infrastructure—Spain
Hospital Landscape and MI Equipment Infrastructure—United Kingdom
Growth Opportunity 1—Increased Adoption of Cyclotrons for the In-house Production of Radionuclides
Growth Opportunity 1—Increased Adoption of Cyclotrons for the In-house Production of Radionuclides (continued)
Growth Opportunity 2—AI Platforms in MI for Improved Patient Care
Growth Opportunity 2—AI Platforms in MI for Improved Patient Care (continued)
Growth Opportunity 3—Favorable Reimbursement Policies to Encourage Molecular Imaging to Enter New Therapeutic Areas such as Neurology
Growth Opportunity 3—Favorable Reimbursement Policies to Encourage Molecular Imaging to Enter New Therapeutic Areas such as Neurology (continued)
List of Exhibits
List of Exhibits (continued)
Legal Disclaimer
- Molecular Imaging Procedures: Key Growth Metrics, Global, 2021
- Molecular Imaging Procedures: Procedures Forecast, Global, 2019–2026
- Molecular Imaging Procedures: Procedures Forecast by Product Segment, Global, 2019–2026
- Molecular Imaging Procedures: PET/CT Procedure Volume Percent by Clinical Application, Global, 2021
- Molecular Imaging Procedures: PET/CT Procedure Volume Percent Forecast by Clinical Application, Global, 2026
- Molecular Imaging Procedures: PET/CT Procedure Volume by Clinical Application, Global, 2019–2026
- Molecular Imaging Procedures: Procedure Volume by Geography, Global, 2019–2026
- Molecular Imaging Procedures: SPECT/CT Procedure Volume Percent by Clinical Application, North America, 2021
- Molecular Imaging Procedures: SPECT/CT Procedure Volume Percent Forecast by Clinical Application, North America, 2026
- Molecular Imaging Procedures: SPECT/CT Procedure Volume by Clinical Application, Global, 2019–2026
- Molecular Imaging Procedures: SPECT/CT Estimated procedures by Geography, Global, 2019–2026
- Molecular Imaging Procedures: Installed Cyclotron Base, Global, 2020
- Molecular Imaging Procedures: Cyclotron Installed Base by Manufacturer, Global, 2020
- Molecular Imaging Procedures: Procedure Volumes by Care Settings, the United States, 2021
- Molecular Imaging Procedures: Procedure Volumes by Care Settings, Germany, 2021
- Molecular Imaging Procedures: Procedure Volumes by Care Settings, France, 2021
- Molecular Imaging Procedures: Procedure Volumes by Care Settings, Italy, 2021
- Molecular Imaging Procedures: Procedure Volumes by Care Settings, Spain, 2021
- Molecular Imaging Procedures: Procedure Volumes by Care Settings, UK, 2021
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
16 Nov 2026 | North America | Frost Radar
Frost Radar™: Healthcare Data Interoperability Platforms and Integration Engines in North America, 2026
This Frost Radar™ analyzes the healthcare data platform and integration engine vendors that enable healthcare organization to improve the exchange, utilization, contextualization, and management of clinical, operational, financial, and administrative data. Data issues, AI adoption, and solution gove...
03 Nov 2026 | North America | Market Research
Enterprise Imaging Market, United States, 2025–2030
Enterprise imaging is no longer a technology upgrade. It is becoming the operating model for imaging across the provider organization, and the next investment cycle will decide which vendors lead it. This study gives vendors, ecosystem partners, and provider leaders a 360-degree view of that shift, ...
02 Nov 2026 | Global | Market Research
Continuous Glucose Monitoring Market, Global, 2026
The global continuous glucose monitoring (CGM) market is undergoing a fundamental transformation as the technology evolves from a prescription-led glucose monitoring device into an AI-connected metabolic intelligence ecosystem. Market expansion is increasingly driven by the emergence of over-the-cou...
28 Oct 2026 | Global | Frost Radar
Frost Radar™: Health Monitoring Wearable Solutions, 2026
The health monitoring wearables industry is undergoing a profound transformation as competitive advantage shifts from device hardware to integrated digital health ecosystems. Market leaders are differentiating through clinically validated health insights, longitudinal data platforms, AI-enabled anal...
26 Oct 2026 | Global | Technology Research
Game-Changing Innovations Transforming Cardiovascular Care
The study analyzes game-changing technologies transforming cardiovascular care across diagnosis, image-guided intervention, functional assessment, clinical workflow, and longitudinal patient monitoring. The analysis covers five segments: diagnostic imaging and AI-enabled cardiac assessment; interve...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.